Robert Carey
CIK 1602064 · EVP, Chief Business Officer · last filed 2025-11-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.06M
Companies
4
Total Filings
71
Lifetime Open-Market Net
$8.91M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XAIR | Director | 5,543,490 | $0.37 | $2.06M | $9.42M | 36 | 2025-11-07 |
| SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Director | 99,600 | $0.18 | $17.7K | $0 | 11 | 2025-06-16 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | EVP, Chief Business Officer | 266,358 | $116.30 | $30.98M | -$509.8K | 17 | 2019-03-25 |
| ARGOS THERAPEUTICS INC (ARGS) Delisted | Director | 8,206 | — | — | $0 | 6 | 2017-01-20 |
Recent Filings · Page 4 of 8
71 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-24 | XAIR | Buy (P) | +10,000 | $120.5K | EDGAR |
| 2021-11-23 | XAIR | Buy (P) | +12,000 | $169.2K | EDGAR |
| 2021-06-21 | XAIR | Buy (P) | +350,000 | $1.88M | EDGAR |
| 2021-03-08 | XAIR | Grant (A) | — | $0 | EDGAR |
| 2021-03-05 | XAIR | Buy (P) | +17,000 | $96.9K | EDGAR |
| 2021-03-01 | SANGAMO THERAPEUTICS, INC (SGMO) Delisted | Grant (A) | +8,200 | $0 | EDGAR |
| 2021-02-18 | XAIR | Buy (P) | +15,000 | $100.0K | EDGAR |
| 2020-08-26 | XAIR | Buy (P) | +10,000 | $57.0K | EDGAR |
| 2020-08-18 | XAIR | Buy (P) | +60,000 | $337.5K | EDGAR |
| 2020-08-17 | XAIR | Buy (P) | +10,000 | $53.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.